Merit Financial Group, LLC Abbott Laboratories Transaction History

Merit Financial Group, LLC

$4.59 Billion
Q3 2024

A detailed history of Merit Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Merit Financial Group, LLC holds 43,024 shares of ABT stock, worth $4.95 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

43,024

Previous 43,353 0.76%

Holding current value

$4.95 Million

Previous $4.5 Million 8.9%

% of portfolio

0.11%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$100.07 - $118.13 $32,923 - $38,864	-329 Reduced 0.76%	43,024 $4.91 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $289,598 - $323,265	-2,875 Reduced 6.22%	43,353 $4.5 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $2.4 Million - $2.65 Million	21,889 Added 89.93%	46,228 $5.25 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $140,065 - $171,451	-1,553 Reduced 6.0%	24,339 $2.68 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $140,429 - $168,491	1,470 Added 6.02%	25,892 $2.51 Million
Q2 2023 Aug 01, 2023	BUY	$100.78 - $112.29 $175,659 - $195,721	1,743 Added 7.69%	24,422 $2.66 Million
Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $192,654 - $226,765	1,989 Added 9.61%	22,679 $2.3 Million
Q4 2022 Jan 13, 2023	BUY	$95.06 - $111.52 $95,440 - $111,966	1,004 Added 5.1%	20,690 $0
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $78,956 - $91,416	816 Added 4.32%	19,686 $1.91 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $769,505 - $930,086	7,539 Added 66.53%	18,870 $2.05 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $72,972 - $88,985	640 Added 5.99%	11,331 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $21,373 - $26,170	185 Added 1.76%	10,691 $1.51 Million
Q3 2021 Oct 27, 2021	BUY	$116.66 - $129.06 $89,828 - $99,376	770 Added 7.91%	10,506 $1.24 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $36,074 - $42,464	341 Added 3.63%	9,736 $1.13 Million
Q1 2021 May 18, 2021	BUY	$108.84 - $128.23 $207,231 - $244,149	1,904 Added 25.42%	9,395 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $89,670 - $97,714	-854 Reduced 10.23%	7,491 $820,000
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $73,037 - $88,698	797 Added 10.56%	8,345 $908,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $211,026 - $270,088	2,756 Added 57.51%	7,548 $690,000
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $48,936 - $71,558	-779 Reduced 13.98%	4,792 $378,000
Q4 2019 Jan 16, 2020	BUY	$78.51 - $87.4 $437,379 - $486,905	5,571 New	5,571 $484,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Account

Merit Financial Group, LLC Abbott Laboratories Transaction History